Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Yau

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Scientific Reports|March 15, 2016
Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching PathwaysMichael C Ryczko, Judy Pawling, Rui Chen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2025
COVID-19 infection and the progression of kidney disease in British Columbia, CanadaMohammad Atiquzzaman, Lee Er, Ognjenka Djurdjev, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 19, 2020
COVID-19 Outbreak in an Urban Hemodialysis UnitKevin Yau, Matthew P Muller, Molly Lin, et al.
Canadian Journal of Kidney Health and Disease|January 31, 2024
Humoral Response Following 3 Doses of mRNA COVID-19 Vaccines in Patients With Non-Dialysis-Dependent CKD: An Observational StudyOmosomi Enilama, Kevin Yau, Lee Er, et al.
Annals of Hepatology|August 15, 2024
Evaluation of four chatbots in autoimmune liver disease: A comparative analysisJimmy Daza, Lucas Soares Bezerra, Laura Santamaría, et al.
JAMA Internal Medicine|April 28, 2025
SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS InhibitorsSara Wing, Joel G Ray, Kevin Yau, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2023
Effectiveness of Three Doses of mRNA COVID-19 Vaccines in the Hemodialysis Population during the Omicron PeriodSara Wing, Doneal Thomas, Shabnam Balamchi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2023
BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis PatientsKevin Yau, Paul Tam, Christopher T Chan, et al.
Journal of the American Society of Nephrology : JASN|March 10, 2022
Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, CanadaMatthew J Oliver, Doneal Thomas, Shabnam Balamchi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 14, 2025
Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKDKevin Yau, Joel G Ray, Nivethika Jeyakumar, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Scientific Reports|March 15, 2016
Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching PathwaysMichael C Ryczko, Judy Pawling, Rui Chen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2025
COVID-19 infection and the progression of kidney disease in British Columbia, CanadaMohammad Atiquzzaman, Lee Er, Ognjenka Djurdjev, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 19, 2020
COVID-19 Outbreak in an Urban Hemodialysis UnitKevin Yau, Matthew P Muller, Molly Lin, et al.
Canadian Journal of Kidney Health and Disease|January 31, 2024
Humoral Response Following 3 Doses of mRNA COVID-19 Vaccines in Patients With Non-Dialysis-Dependent CKD: An Observational StudyOmosomi Enilama, Kevin Yau, Lee Er, et al.
Annals of Hepatology|August 15, 2024
Evaluation of four chatbots in autoimmune liver disease: A comparative analysisJimmy Daza, Lucas Soares Bezerra, Laura Santamaría, et al.
JAMA Internal Medicine|April 28, 2025
SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS InhibitorsSara Wing, Joel G Ray, Kevin Yau, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2023
Effectiveness of Three Doses of mRNA COVID-19 Vaccines in the Hemodialysis Population during the Omicron PeriodSara Wing, Doneal Thomas, Shabnam Balamchi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2023
BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis PatientsKevin Yau, Paul Tam, Christopher T Chan, et al.
Journal of the American Society of Nephrology : JASN|March 10, 2022
Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, CanadaMatthew J Oliver, Doneal Thomas, Shabnam Balamchi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 14, 2025
Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKDKevin Yau, Joel G Ray, Nivethika Jeyakumar, et al.
Pageof 5